Br J Urol 1998 Dec;82 Suppl 1:47-58

Department of Urology, St George's Hospital NHS Trust, London, UK.

December 1998
8 Reads

Publication Analysis

Top Keywords

changes prostate
prostate ageing
malignant changes

Similar Publications

Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.

Arch Biochem Biophys 2003 Feb;410(1):177-85

Department of Urology, Jim & Eillen Dicke Research Laboratory, Case Western Reserve University, The Research Institute of University Hospitals of Cleveland, Cleveland, OH 44106, USA.

Epigallocatechin-3-gallate (EGCG), the major polyphenolic constituent present in green tea, is a promising chemopreventive agent. We recently showed that green tea polyphenols exert remarkable preventive effects against prostate cancer in a mouse model and many of these effects are mediated by the ability of polyphenols to induce apoptosis in cancer cells [Proc. Natl. Read More

View Article
February 2003

Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate.

David Danielpour

Eur J Cancer 2005 Apr;41(6):846-57

Case Comprehensive Cancer Center and Department of Pharmacology, Case Western Reserve University, Wolstein Research Building, Room 3-532, 2103 Cornell Road, Cleveland, OH 44106, USA.

The prostate is a highly androgen-dependent tissue that in humans exhibits marked susceptibility to carcinogenesis. The malignant epithelium generated from this tissue ultimately loses dependence on androgens despite retention or amplification of the androgen receptor. Accumulating evidence support that transforming growth factor-beta (TGF-beta) plays key roles in the control of androgen dependence and acquisition of resistance to such hormonal control. Read More

View Article
April 2005

Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis.

Prostate 2005 Sep;64(4):332-40

Department of Urology, University of Innsbruck, Innsbruck, Austria.

Background: RhoE/Rnd3, a recently described novel member of the Rho GTPases family, was discussed as a possible antagonist of the RhoA protein that stimulates cell cycle progression and is overexpressed and/or overactivated in prostate cancer. We investigated the expression of RhoE and its role in cell cycle regulation and apoptosis in the human prostate.

Methods: RhoE expression in cell lines and tissue specimens was assessed by immunoblot analysis, real-time PCR (RT-PCR), and immunohistochemistry. Read More

View Article
September 2005

Cell proliferation and apoptosis in prostate tumors and adjacent non-malignant prostate tissue in patients at different time-points after castration treatment.

Prostate 2005 Mar;62(4):307-15

Department of Medical Biosciences, Pathology, and Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.

Background: Androgen ablation is the standard treatment for advanced prostate cancer but the short-term cellular effects are largely unknown.

Methods: Sextant prostate biopsies were taken from 77 prostate cancer patients before and 1-10 days after castration treatment. Apoptosis, cell proliferation, and morphology were studied in malignant and non-malignant tissue, using stereological and immunohistochemical methods. Read More

View Article
March 2005